Four of the world’s most advanced artificial intelligence companies have formed a group to research increasingly powerful AI and establish best practices for controlling it, as public anxiety and ...

Psilocybin trials show poorer control group outcomes compared to SSRIs and esketamine, potentially inflating perceived efficacy due to expectancy bias and functional unblinding. Control group response ...